According to a report from Bloomberg, Russian officials have denied a report stating that a second case of illness had been identified in Siberia. The denial comes in response to the initial report, which cited the discovery of a second case. The news was published on October 8, 2026.
The filing also lists Moderna Inc. (NASDAQ:MRNA) and Novavax Inc. (NVAX) as stocks mentioned in the context of the report, with their respective stock prices listed as $195.18 and $11.09.
